Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:
Switzerland
Page logo
Our Company

Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference

New Brunswick, NJ (May 29, 2018) -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, at the Terranea Resort in Rancho Palos Verdes, California. Tom Cavanaugh, President, Oncology, Janssen Pharmaceuticals and Scott White, President, Immunology will represent the Company in a session scheduled at 9:20 a.m. (Pacific Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

  • Press Contacts:
    Ernie Knewitz
    (732) 524-6623
    (917) 697-2318 (M)

    Cristal Downing
    (732) 524-3283
    (908) 616-8833 (M)

    Investor Contacts:
    Joseph J. Wolk
    (732) 524-1142

    Lesley Fishman
    (732) 524-3922
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue